Dr. Tadashi Urashima is Performance and Digital Analytics Lead at GSK Japan. In this position, Dr. Urashima is responsible for leading digital transformation in Development and Medical Affairs. Also, Dr. Urashima has over 20 years’ experience in pharmaceutical company and has played roles in clinical development, project management, medical excellence, MSL Manager. Dr. Urashima is in charge of MA community lead and content committee in DIA Japan. He has organized DIA MA forum or DIA MA short course as program chairman. Dr. Urashima holds a PhD in regenerative medicine from Tottori University and has a certification of Associated Certified Coach (ACC) in International Coaching Federation.

Takeshi Shukunobe was born in 1968. Mr. Shukunobe bacame chronic nephritis when he was 3 years old and initiated dialysissince because of chronic renal failure when he was 18 years old. In 2008, his left kidney was removed in a nephrectomy because of kidney cancer. He is the physically handicapped and licensed social worker. Mr. Shukunobe left Sony Corporation which he had worked for 14 years, then obtained certificate on social worker and started buisiness, patienthood, in 2010. PPeCC,Inc. was started in 2019. Patienthood was merged into PPeCC,Inc. in 2020. He gives lecture and training based on his experience as a patient and has many connection with health care providers, health care companies, patient organizations and pateints.

Hideki Ninomiya graduated from the University of Tokyo's School of Medicine. After working as a neurosurgeon, he entered the world of data science. He engaged in medical information and telemedicine at Medley Inc. Afterwards, he started his own company, Datack Inc.

Dr. Yoshiyuki Sugimoto is the Scientifica Advisor in Medical Affairs at AbbVie Japan. Dr. Sugimoto graduated from Faculty of Pharmaceutical Sciences, the University of Tokyo in 1998 and completed Master's course at Graduate School of Pharmaceutical Science, the University of Tokyo in 2000. Dr. Sugimoto Joined Kyowa Hakko Kogyo Co., Ltd. (current Kyowa Kirin Co., Ltd.) in 2000, and moved to AbbVie Japan in 2016. Dr. Sugimoto has over 20 years’ experience in Pharmaceutical industry including Research, Development and Medical Affairs. Currently Dr. Sugimoto works for Rheumatology Medical Affairs Team and plays a leading role in the strategy of rheumatology field. Dr. Sugimoto obtained PhD degree from Waseda University in 2014.

Shuji Uno has served as Medical Lead at Medical Affairs department in BMS K.K. since July 2020. Shuji is responsible for Medical Plan development via UMNs identification and any activities of Evidence Generation in hematology area, such as company-sponsored studies, investigator-sponsored studies, and publication. He has over 8 years of experineces in Medical Affairs department including field work experiences as MSL in pharmaceutical industry. He holds a Ph.D. in life science from University of Tokyo.

Dr. Shinichi Nishiuma is Executive Officer, Chief Medical Officer at Aculys Pharma Inc. After graduating from Kobe University School of Medicine in 1997, he began his medical career as an internist and a gastroenterologist at Kobe City General Hospital. Recognizing issues with the drug lag for hepatitis C treatment, he took on the role of a physician in clinical development at Schering-Plough (now merged into MSD). Following that, he was responsible for clinical development and safety management at Eli Lilly Japan. From 2018, he served as the Head of Medical Division at Celgene Japan (now merged into BMS). In 2022, he became the Chief Medical Officer at Aculys Pharma Inc., where he remains to this day.

Mr. Yuta Kasai is a member of Clinical Patient Experience Team in Astellas Pharma Inc. and in charge of implementation of various Patient Engagement approaches into clinical operation in the company. He is dedicated to this role and he is supporting clinical study team to implement PE approches in clinical development department mainly in JP. In addition, He is assigned to Patient Engagement Workstream in Transcelerate Biopharma Inc. and working to make PE activities more popular approach in clinical trial in Japan. Before he is assigened to current role, he worked as a clinical study manager in JP for some years.